1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Infectious Diseases Molecular Diagnostics Market Size 2017-2028 2.1.2 Infectious Diseases Molecular Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028 2.2 Infectious Diseases Molecular Diagnostics Segment by Type 2.2.1 Polymerase Chain Reaction PCR 2.2.2 Molecular Hybridization 2.2.3 Biochip 2.2.4 Other 2.3 Infectious Diseases Molecular Diagnostics Market Size by Type 2.3.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) 2.3.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022) 2.4 Infectious Diseases Molecular Diagnostics Segment by Application 2.4.1 Hospital 2.4.2 Third-party Testing Agency 2.4.3 Other 2.5 Infectious Diseases Molecular Diagnostics Market Size by Application 2.5.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) 2.5.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022) 3 Infectious Diseases Molecular Diagnostics Market Size by Player 3.1 Infectious Diseases Molecular Diagnostics Market Size Market Share by Players 3.1.1 Global Infectious Diseases Molecular Diagnostics Revenue by Players (2020-2022) 3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Players (2020-2022) 3.2 Global Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Infectious Diseases Molecular Diagnostics by Regions 4.1 Infectious Diseases Molecular Diagnostics Market Size by Regions (2017-2022) 4.2 Americas Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022) 4.3 APAC Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022) 4.4 Europe Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022) 4.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022) 5 Americas 5.1 Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) 5.2 Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) 5.3 Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022) 6.2 APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) 6.3 APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Infectious Diseases Molecular Diagnostics by Country (2017-2022) 7.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) 7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Infectious Diseases Molecular Diagnostics by Region (2017-2022) 8.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) 8.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Infectious Diseases Molecular Diagnostics Market Forecast 10.1 Global Infectious Diseases Molecular Diagnostics Forecast by Regions (2023-2028) 10.1.1 Global Infectious Diseases Molecular Diagnostics Forecast by Regions (2023-2028) 10.1.2 Americas Infectious Diseases Molecular Diagnostics Forecast 10.1.3 APAC Infectious Diseases Molecular Diagnostics Forecast 10.1.4 Europe Infectious Diseases Molecular Diagnostics Forecast 10.1.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast 10.2 Americas Infectious Diseases Molecular Diagnostics Forecast by Country (2023-2028) 10.2.1 United States Infectious Diseases Molecular Diagnostics Market Forecast 10.2.2 Canada Infectious Diseases Molecular Diagnostics Market Forecast 10.2.3 Mexico Infectious Diseases Molecular Diagnostics Market Forecast 10.2.4 Brazil Infectious Diseases Molecular Diagnostics Market Forecast 10.3 APAC Infectious Diseases Molecular Diagnostics Forecast by Region (2023-2028) 10.3.1 China Infectious Diseases Molecular Diagnostics Market Forecast 10.3.2 Japan Infectious Diseases Molecular Diagnostics Market Forecast 10.3.3 Korea Infectious Diseases Molecular Diagnostics Market Forecast 10.3.4 Southeast Asia Infectious Diseases Molecular Diagnostics Market Forecast 10.3.5 India Infectious Diseases Molecular Diagnostics Market Forecast 10.3.6 Australia Infectious Diseases Molecular Diagnostics Market Forecast 10.4 Europe Infectious Diseases Molecular Diagnostics Forecast by Country (2023-2028) 10.4.1 Germany Infectious Diseases Molecular Diagnostics Market Forecast 10.4.2 France Infectious Diseases Molecular Diagnostics Market Forecast 10.4.3 UK Infectious Diseases Molecular Diagnostics Market Forecast 10.4.4 Italy Infectious Diseases Molecular Diagnostics Market Forecast 10.4.5 Russia Infectious Diseases Molecular Diagnostics Market Forecast 10.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast by Region (2023-2028) 10.5.1 Egypt Infectious Diseases Molecular Diagnostics Market Forecast 10.5.2 South Africa Infectious Diseases Molecular Diagnostics Market Forecast 10.5.3 Israel Infectious Diseases Molecular Diagnostics Market Forecast 10.5.4 Turkey Infectious Diseases Molecular Diagnostics Market Forecast 10.5.5 GCC Countries Infectious Diseases Molecular Diagnostics Market Forecast 10.6 Global Infectious Diseases Molecular Diagnostics Forecast by Type (2023-2028) 10.7 Global Infectious Diseases Molecular Diagnostics Forecast by Application (2023-2028) 11 Key Players Analysis 11.1 Roche 11.1.1 Roche Company Information 11.1.2 Roche Infectious Diseases Molecular Diagnostics Product Offered 11.1.3 Roche Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.1.4 Roche Main Business Overview 11.1.5 Roche Latest Developments 11.2 Qiagen 11.2.1 Qiagen Company Information 11.2.2 Qiagen Infectious Diseases Molecular Diagnostics Product Offered 11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.2.4 Qiagen Main Business Overview 11.2.5 Qiagen Latest Developments 11.3 Illumina 11.3.1 Illumina Company Information 11.3.2 Illumina Infectious Diseases Molecular Diagnostics Product Offered 11.3.3 Illumina Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.3.4 Illumina Main Business Overview 11.3.5 Illumina Latest Developments 11.4 Abbott 11.4.1 Abbott Company Information 11.4.2 Abbott Infectious Diseases Molecular Diagnostics Product Offered 11.4.3 Abbott Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.4.4 Abbott Main Business Overview 11.4.5 Abbott Latest Developments 11.5 Hologic 11.5.1 Hologic Company Information 11.5.2 Hologic Infectious Diseases Molecular Diagnostics Product Offered 11.5.3 Hologic Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.5.4 Hologic Main Business Overview 11.5.5 Hologic Latest Developments 11.6 BioMerieux 11.6.1 BioMerieux Company Information 11.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Product Offered 11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.6.4 BioMerieux Main Business Overview 11.6.5 BioMerieux Latest Developments 11.7 Danaher (Cepheid) 11.7.1 Danaher (Cepheid) Company Information 11.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered 11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.7.4 Danaher (Cepheid) Main Business Overview 11.7.5 Danaher (Cepheid) Latest Developments 11.8 Myriad Genetics 11.8.1 Myriad Genetics Company Information 11.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered 11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.8.4 Myriad Genetics Main Business Overview 11.8.5 Myriad Genetics Latest Developments 11.9 DAAN Gene 11.9.1 DAAN Gene Company Information 11.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered 11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.9.4 DAAN Gene Main Business Overview 11.9.5 DAAN Gene Latest Developments 11.10 Agilent 11.10.1 Agilent Company Information 11.10.2 Agilent Infectious Diseases Molecular Diagnostics Product Offered 11.10.3 Agilent Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.10.4 Agilent Main Business Overview 11.10.5 Agilent Latest Developments 11.11 Genomic Health 11.11.1 Genomic Health Company Information 11.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Product Offered 11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.11.4 Genomic Health Main Business Overview 11.11.5 Genomic Health Latest Developments 11.12 BD 11.12.1 BD Company Information 11.12.2 BD Infectious Diseases Molecular Diagnostics Product Offered 11.12.3 BD Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.12.4 BD Main Business Overview 11.12.5 BD Latest Developments 11.13 Foundation Medicine 11.13.1 Foundation Medicine Company Information 11.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered 11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022) 11.13.4 Foundation Medicine Main Business Overview 11.13.5 Foundation Medicine Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Infectious Diseases Molecular Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions) Table 2. Major Players of Polymerase Chain Reaction PCR Table 3. Major Players of Molecular Hybridization Table 4. Major Players of Biochip Table 5. Major Players of Other Table 6. Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions) Table 7. Global Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions) Table 8. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022) Table 9. Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions) Table 10. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions) Table 11. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022) Table 12. Global Infectious Diseases Molecular Diagnostics Revenue by Players (2020-2022) & ($ Millions) Table 13. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player (2020-2022) Table 14. Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered Table 15. Infectious Diseases Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Infectious Diseases Molecular Diagnostics Market Size by Regions 2017-2022 & ($ Millions) Table 19. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Regions (2017-2022) Table 20. Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & ($ Millions) Table 21. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2017-2022) Table 22. Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions) Table 23. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022) Table 24. Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions) Table 25. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022) Table 26. APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022) & ($ Millions) Table 27. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2017-2022) Table 28. APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions) Table 29. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022) Table 30. APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions) Table 31. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022) Table 32. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & ($ Millions) Table 33. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2017-2022) Table 34. Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions) Table 35. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022) Table 36. Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions) Table 37. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022) Table 38. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022) & ($ Millions) Table 39. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2017-2022) Table 40. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions) Table 41. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022) Table 42. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions) Table 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022) Table 44. Key Market Drivers & Growth Opportunities of Infectious Diseases Molecular Diagnostics Table 45. Key Market Challenges & Risks of Infectious Diseases Molecular Diagnostics Table 46. Key Industry Trends of Infectious Diseases Molecular Diagnostics Table 47. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions) Table 48. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Regions (2023-2028) Table 49. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions) Table 50. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Type (2023-2028) Table 51. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions) Table 52. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Application (2023-2028) Table 53. Roche Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 54. Roche Infectious Diseases Molecular Diagnostics Product Offered Table 55. Roche Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 56. Roche Main Business Table 57. Roche Latest Developments Table 58. Qiagen Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 59. Qiagen Infectious Diseases Molecular Diagnostics Product Offered Table 60. Qiagen Main Business Table 61. Qiagen Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 62. Qiagen Latest Developments Table 63. Illumina Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 64. Illumina Infectious Diseases Molecular Diagnostics Product Offered Table 65. Illumina Main Business Table 66. Illumina Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 67. Illumina Latest Developments Table 68. Abbott Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 69. Abbott Infectious Diseases Molecular Diagnostics Product Offered Table 70. Abbott Main Business Table 71. Abbott Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 72. Abbott Latest Developments Table 73. Hologic Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 74. Hologic Infectious Diseases Molecular Diagnostics Product Offered Table 75. Hologic Main Business Table 76. Hologic Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 77. Hologic Latest Developments Table 78. BioMerieux Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 79. BioMerieux Infectious Diseases Molecular Diagnostics Product Offered Table 80. BioMerieux Main Business Table 81. BioMerieux Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 82. BioMerieux Latest Developments Table 83. Danaher (Cepheid) Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 84. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered Table 85. Danaher (Cepheid) Main Business Table 86. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 87. Danaher (Cepheid) Latest Developments Table 88. Myriad Genetics Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 89. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered Table 90. Myriad Genetics Main Business Table 91. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 92. Myriad Genetics Latest Developments Table 93. DAAN Gene Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 94. DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered Table 95. DAAN Gene Main Business Table 96. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 97. DAAN Gene Latest Developments Table 98. Agilent Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 99. Agilent Infectious Diseases Molecular Diagnostics Product Offered Table 100. Agilent Main Business Table 101. Agilent Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 102. Agilent Latest Developments Table 103. Genomic Health Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 104. Genomic Health Infectious Diseases Molecular Diagnostics Product Offered Table 105. Genomic Health Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 106. Genomic Health Main Business Table 107. Genomic Health Latest Developments Table 108. BD Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 109. BD Infectious Diseases Molecular Diagnostics Product Offered Table 110. BD Main Business Table 111. BD Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 112. BD Latest Developments Table 113. Foundation Medicine Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors Table 114. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered Table 115. Foundation Medicine Main Business Table 116. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 117. Foundation Medicine Latest Developments List of Figures Figure 1. Infectious Diseases Molecular Diagnostics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate 2017-2028 ($ Millions) Figure 6. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2021 Figure 7. Infectious Diseases Molecular Diagnostics in Hospital Figure 8. Global Infectious Diseases Molecular Diagnostics Market: Hospital (2017-2022) & ($ Millions) Figure 9. Infectious Diseases Molecular Diagnostics in Third-party Testing Agency Figure 10. Global Infectious Diseases Molecular Diagnostics Market: Third-party Testing Agency (2017-2022) & ($ Millions) Figure 11. Infectious Diseases Molecular Diagnostics in Other Figure 12. Global Infectious Diseases Molecular Diagnostics Market: Other (2017-2022) & ($ Millions) Figure 13. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021 Figure 14. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player in 2021 Figure 15. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Regions (2017-2022) Figure 16. Americas Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions) Figure 17. APAC Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions) Figure 18. Europe Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions) Figure 19. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions) Figure 20. Americas Infectious Diseases Molecular Diagnostics Value Market Share by Country in 2021 Figure 21. Americas Infectious Diseases Molecular Diagnostics Consumption Market Share by Type in 2021 Figure 22. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021 Figure 23. United States Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 24. Canada Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 25. Mexico Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 26. Brazil Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 27. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2021 Figure 28. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021 Figure 29. China Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 30. Japan Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 31. Korea Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 32. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 33. India Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 34. Australia Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 35. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2021 Figure 36. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2021 Figure 37. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021 Figure 38. Germany Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 39. France Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 40. UK Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 41. Italy Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 42. Russia Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2021 Figure 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2021 Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021 Figure 46. Egypt Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 47. South Africa Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 48. Israel Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 49. Turkey Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 50. GCC Country Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions) Figure 51. Americas Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 52. APAC Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 53. Europe Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 54. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 55. United States Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 56. Canada Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 57. Mexico Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 58. Brazil Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 59. China Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 60. Japan Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 61. Korea Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 62. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 63. India Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 64. Australia Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 65. Germany Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 66. France Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 67. UK Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 68. Italy Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 69. Russia Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 70. Spain Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 71. Egypt Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 72. South Africa Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 73. Israel Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 74. Turkey Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions) Figure 75. GCC Countries Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)